Mucosal and systemic immunization using cochleate and liposome vaccines

Journal of Liposome Research

Volumn 6, Issue 2, 1996, Pages 357-379

  Gould Fogerite, Susan ^a   Mannino, Raphael J ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; COCHLEATE; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANTIBODY RESPONSE; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; EFFECTOR CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFECTION; MICROBIAL GROWTH; MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW;

EID: 0029977689     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109609031122     Document Type: Review

References (34)

1. Miller, M.D., Gould-Fogerite, S., Shen, L., Woods, R.M., Koenig, S., Mannino, R.J. and Letvin, N. 1992. Vaccination of Rhesus Monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes, J. Exp. Med. 176:1739.
2. Gould-Fogerite S, Edghill-Smith, Y., Kheiri, M., Wang, Z., Das, K., Feketeova, E., Canki, M. and Mannino R.J. 1994. Lipid matrix-based subunit vaccines:A structure -function approach to oral and parenteral immunization. AIDS Res. and Hum. Retrovirus. 10:s99.
3. Marrack, P and Kappler, J. Subversion of the Immune System by Pathogens. Cell, 76: 323.
4. Gregoriadis, G. 1990. Immunological adjuvants: A role for liposomes, Immunol. Today. 11:89-97.
5. Goodman-Snitkoff, G., Eisele, L.E., Heimer, E.P., Felix, A.M. Andersen, T.T., Fuerst, T.R., and Mannino, R.J., 1990, Defining minimal requirements for antibody production to peptide antigens, Vaccine, 8:257-262.
6. Goodman-Snitkoff, G., Good, M.F., Berzofsky, J.A., and Mannino, R.J. 1991. Role of Intrastructural/Intermolecular help in immunization with peptide-phospholipid complexes. Journal of Immunology 147:410-415
7. Goodman-Snitkoff, G., Heimer, E., Danho, W., Felix, A., and Mannino, R.J., 1988, Induction of antibody production to synthetic peptides viapeptide-phospholipid complexes. In: Technological Advances in VaccineDevelopment. Alan R. Liss, Inc., pp 335-344.
8. Mannino, R.J., Gould-Fogerite, S. and Goodman-Snitkoff, G., 1992, Liposomes as adjuvants for peptides: Preparation and use of immunogenic peptide-phospholipid complexes, in: Liposome Technology: 2nd Edition. (G. Gregoriadis, ed.) CRC Press, Boca Raton, Florida, Vol II, pp. 168-183.
9. Gould-Fogerite, S. and Mannino, R.J. 1992. Targeted fusogenic liposomes:Functional reconstitution of membrane proteins into large unilamellar vesicles via protein-cochleate intermediates, in: Liposome Technology: 2ndEdition, Vol III(G. Gregoriadis, ed.) CRC Press, Inc., Boca Raton, Florida-, pp. 262-275.
10. Gould-Fogerite, S., Kheiri, M., Edghill-Smith, Y., Das, K.D., Wang, Z., Feketeova, E., and Mannino, R.J., 1994, Orally delivered protein cochleate vaccines stimulate mucosal and circulating immunity and protection from mucosal challenge with live influenza virus, submitted
11. Mannino, R.J. and Gould-Fogerite, S. 1995. Lipid matrix-based vaccines for mucosal and systemic immunization. In "Vaccine Design: The Subunit and Adjuvant approach" M.F. Powell and M.J. Newman (Eds.). Plenum Press, New York, p363.
12. Mannino, R.J. and Gould-Fogerite, S., 1988, Liposome Mediated Gene Transfer, Biotechniques 6:682-690.
13. Gould-Fogerite, S., Mazurkiewicz, J., Lehman, J., Raska, Jr., K., Voelkerding, K., and Mannino, R.J., 1989, Chimerasome-mediated gene transfer in vitro and in vivo. Gene, 84: 429-438.
14. El Guink, N., Kris, R., Goodman-Snitkoff, G.W., Small, P.A. and Mannino, R.J., 1989, Intranasal immunization with proteoliposomes protects against influenza, Vaccine. 7: 147-151.
15. Kheiri, M., Feketeova, E., Mannino, R.J., and Gould-Fogerite, S., 1994, Mucosal and systemic responses to influenza glycoproteins in protein cochleates, manuscript in preparation.
16. Edghill-Smith, Y., Feketeova, E., Wang, Z., Mannino, R.J., and Gould-Fogerite, S., 1994a, A new type of subunit vaccine induces mucosal and systemic responses to parainfluenza type I virus, in preparation.
17. Morein, B. and Simons, K., 1985, Subunit vaccines against enveloped viruses:Virosomes, micelles and other protein complexes, Vaccine 3, 83.
18. Muller, G.M., Shapira, M. and Arnon, R., 1982, Anti-influenza response achieved by immunization with a synthetic conjugate, Proc. Natl. Acad. Sci. USA.79, 569-573.
19. Allen PM., 1987, Antigen processing at the molecular level, Immunol Today .8:270-273.
20. Gould-Fogerite, S. and Mannino, R.J. 1985 Rotary dialysis: Its application to the production of large liposomes and large proteoliposomes (protein-lipid vesicles) with high encapsulation efficiency and efficient reconstitution of membrane proteins. Anal. Biochem. 148:15.
21. Gould-Fogerite, S., Mazurkiewicz, J.E., Bhisitkul, D., and Mannino, R.J. 1987. The reconstitution of biologically active glycoproteins into large liposomes: Use as a delivery vehicle to animal cells. In "Advances in Membrane Biochemistry and Bioenergetics". C.H. Kim, J. Diwan, H. Tedeschi, and J.J. Salerno (Eds.). Plenum Publishing Corp., New York, p 569.
22. Formal, S.B., Maenza, R.M., Austin, S., and LaBrec, E.H. 1967. Failure of parenteral vaccines to protect monkeys against experimental shigellosis, Proc. Soc. Exp. Biol. Med. 125: 347-349.
23. Cholera. Report of the Committee on Infectious Diseases. 1991. AmericanAcademy of Pediatrics. Elk Grove Village, IL, p. 170.
24. Walker, R.I. 1994. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 12: 387.
25. Horre, D., and Hackett, J., 1989, Vaccination against enteric bacterial diseases, Rev of Inf Dis. 11:853-877.
26. McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M., and Kiyono, H., 1992, The mucosal immune system: From fundamental concepts to vaccine development. Vaccine, 10:75-88.
27. Treanor, J.J., Mattison, H.R., Dumyati, G., Yinnon, A., Erb, S., O'Brien, D., Dolin, R. Betts, R. and Betts, R.F., 1992. Protective efficacy of combined live intranasal and inactivated influenza: A virus vaccines in the elderly, Ann. Intern. Med. 117:625-633.
28. Edghill-Smith, Y., Gould-Fogerite, S., and Mannino, R.J., 1995b, HIV subunit protein and peptide cochleate vaccines, in preparation.
29. Webster, R,G., and Rott, R., 1987, Influenza virus A pathogenicity: The pivotal role of hemagglutinin, Cell 50:665-666.
30. Wilson, J.A., and Cox, N.J., 1990, Structural basis of immune recognition of influenza virus hemagglutinin, Ann Rev Immunol 8:737-771.
31. Mestecky, J. and McGhee, J.R., 1989, Oral immunization: past and present, Curr. Topics Microbiol. Immunol. 146:3-11.
32. Lyn, D., Gill, D.S., Scroggs, R.A., and Portner, A., 1991, The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acidsequences and antigenic and structural determinants, J of Gen Virol. 72:983-987.
33. Komoda, H., Kusagawa, S., Orvell, C., Tsurudome, M., Nishio, M., Bando, H., Kawano, M, Norby, E., and Ito, Y. 1992. Antigenic diversity of human parainfluenza type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies, J. Gen. Virol. 73:875-884.
34. Henrickson, K.J., and Savatski L.L., 1992, Genetic variation and evolution of human parainfluenza virus type 1 hemagglutinin neuraminidase: Analysis of 12 clinical isolates, J. Infect. Dis. 166:995-1005